Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.
She's an Upstate interior designer, he is a passionate golfer. Their Downtown Greenville condo was designed for a new ...
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
The mouse on the right with four times the normal muscle mass is placed with a normal mouse. Handout via REUTERS About a dozen drugmakers are developing new weight-loss treatments aimed at ...
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...
Cory Wendel is ready to show off his new location of Lachele's Fine Foods with fried chicken, hot beef sandwiches and only 3 ...
Vogue Williams and Spencer Matthews are selling their luxurious £4.7million London pad - which has had its price slashed from ...
Netflix's strategic shifts and global expansion drive profitability and value, with a bold $1500+ stock target in 12-18 ...
Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...
U.S.-based hedge fund Viking Global built a $526 million-worth new position in planemaker Boeing in the fourth quarter, with 2.9 million shares, and roughly doubled bets on JPMorgan Chase, a ...
announced today the launch of a new collaboration with the iconic fabric and wallpaper house, Sanderson. The new Sanderson for Mark & Graham collaboration celebrates Sanderson’s quintessentially ...
In this incarnation, Roderick Usher (Bruce Greenwood) and his sister, Madeline Usher (Mary McDonnell), own a powerful pharmaceutical company, and they’ve passed on their ruthless streak to the ...